Business / Economy

Views from the boardroom

(China daily) Updated: 2015-09-24 08:58

Views from the boardroom
Wu Xiaobin, president of Pfizer Investment China: From a pharmaceutical industry perspective, we hope the Chinese government will further implement policies that support and encourage biopharmaceutical innovation, accelerate the approval process of new medicines, and enhance the quality of domestic generics to the international level. More
Views from the boardroom

Huang Chenhong, president, Dell Greater China: China is already a competitive market, and very open. We'll just have to make ourselves more excellent in execution and enhance our competitiveness, and offer better solutions, bringing value to society and our customers. More

Hot Topics

Editor's Picks